Clinical and instrumental characteristics of patients with chronic heart failure and reduced left ventricular ejection fraction depending on renal dysfunction

August 22, 2018

Aim — to compare clinical and instrumental indicators of patients with chronic heart failure (CHF) and reduced left ventricular ejection fraction (LVEF) with renal dysfunction (RD) and without it. Materials and methods. 134 patients with CHF and LVEF were examined. Patients were divided into 2 groups by the the glomerular filtration rate (GFR): the first — <60 ml/min/1.73 m², the second — ≥60 ml/min/1.73 m². GFR was estimated using the CKD-EPI equation. Daily microalbuminuria and urinary albumine/creatinine ratio were determined. Definitions of levels of blood urea nitrogen, uric acid, interleukin (IL)-6, NTproBNP and citrulin were performed. The functional capabilities of the patients were determined using a 6-minute walk test. The quality of life was assessed using the Minnesota Questionnaire. The level of household physical activity was assessed using the Duke University questionnaire. Ultrasound diagnosis of the vasodilating function of the brachial endothelium was performed using a test with reactive hyperemia. Results and conclusions. Among patients with CHF and reduced LVEF, RD was observed in 39.5%. In the group with RD: women, patients with III–IV NYHA class and comorbidities, such as arterial hypertension, stable coronary disease and diabetes, were more common. Patients with RD showed low level of physical activity, worse results with 6-minute walk test, worse quality of life and at the same time were characterized by significantly high levels of uric acid, IL-6 and citrulline. Between groups of patients with and without RD, there were no significant differences in hemodynamic parameters (heart rate, systolic blood pressure, LV EF, end-diastolic volume/body surface area), levels of potassium and NTproBNP, microalbuminuria and endothelium-dependent dilation.

L.G. Voronkov, G.E. Dudnik, A.V. Lyashenko, L.S. Mkhitaryan, T.I. Gavrilenko, G.V. Ponomaryova

Key words: chronic heart failure, renal dysfunction, glomerular filtration rate, microalbuminuria.

Published: 05.09.2018


  • Asotsiatsiia kardiolohiv Ukrainy (2017) Rekomendatsii Asotsiatsii kardiolohiv Ukrainy z diahnostyky ta likuvannia khronichnoi sertsevoi nedostatnosti (2017) (
  • Voronkov L.G., Paraschenyuk L.P. (2010) Kachestvo zhizni pri serdechnoy nedostatochnosti: aktualnyie aspektyi. Sertseva nedostatnIst, 2: 12–16.
  • Giryalevskiy S.R., Orlov V.A., Bendeliana N.G. (2001) Izuchenie kachestva zhizni s hronicheskoy serdechnoy nedostatochnostyu: sovremennoe sostoyanie problemyi. Rus. kardiol. zhurn., 3: 58–72.
  • Ivanov D.D., Korzh O.M. (2014) Khronichna khvoroba nyrok: diahnostyka ta likuvannia. Zaslavskyi O.Iu., Donetsk, 56 s.
  • Mkhitarian L.S., Kuchmenko O.B., Yevstratova I.N. ta in. (2016) Tsytrulin yak marker funktsionalnoho stanu orhaniv za umov patolohichnykh staniv. Ukr. kardiol. zhurn., 3: 109–115.
  • Sirenko Yu.M. (2010) Novi mozhlyvosti vyznachennia mikroalbuminurii v klinichnii praktytsi (dopovidalosia na Vseukrainskii naukovo-praktychnii konferentsii «Profilaktyka i likuvannia arterialnoi hipertenzii» 17 travnia 2010 r. v m. Kyievi) (
  • Bongartz L.G., Cramer M.J., Doevendans P.A. et al. (2005) The severe cardiorenal syndrome: «Guyton revisited». Eur. Heart J., 26(1): 11–17.
  • Celermajer D.S., Sorensen K.E., Bull C. et al. (1994) Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J. Am. Coll. Cardiol., 24(6): 1468–1474.
  • Damman K., Testani J.M. (2015) The kidney in heart failure: an update. Eur. Heart J., 36(23): 1437–1444.
  • Damman K., Valente M.A., Voors A.A. et al. (2014) Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur. Heart J., 35(7): 455–469.
  • Hillege H.L., Girbes A.R., de Kam P.J. et al. (2000) Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation, 102(2): 203–210.
  • KDIGO (2012) KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (
  • Ljungman S., Laragh J.H., Cody R.J. (1990) Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs, 39 Suppl. 4: 10–21.
  • Mann D. (2011) Heart Failure: A Companion to Braunwald’s Heart Disease. 159–192 pp.
  • McDonagh Th.A., Gardner R.S., Clark A.L., Dargie H. (2011) Oxford Textbook of Heart Failure. Oxford Univ. Press, 664 p.
  • Medcalf E.A., Newman D.J., Gorman E.G., Price C.P. (1990) Rapid, robust method for measuring low concentrations of albumin in urine. Clin. Chem., 36(3): 446–449.
  • Myers G.L., Miller W.G., Coresh J. et al.; National Kidney Disease Education Program Laboratory Working Group (2006) Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin. Chem., 52(1): 5–18.
  • Ronco C., Haapio M., House A.A. et al. (2008) Cardiorenal syndrome. J. Am. Coll. Cardiol., 52(19): 1527–1539.
  • Sauntine Y., Johonson R. (2008) Uric acid: the oxidant — antioxidant paradox. Nucleosides Nucleic. Acids, 28: 608–619.
  • Smith G., Lichtman J., Bracken M. et al. (2006) Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J. Am. Coll. Cardiol., 47(10): 1987–1996.
  • Testani J., Damman K., Brisko M. et al. (2014) A combined-biomarker approach tо clinical phenotyping renal dysfunction in heart failure. J. Card. Fail., 20: 912–919.
  • Tonelli M., Wiebe N., Culleton B. et al. (2006) Chronic kidney disease and mortality risk: a systematic revive. J. Am. Soc. Nephrol., 17: 2034–2047.
  • Torre-Amione G., Kapadia S., Lee J. et al. (1996) Tumor necrosis factor-alpha and tumor nesrosis factor receptors in the failing human heart. Cirsulation, 93(4): 704–711.
  • Zima T. (2007) Laboratorna diagnostika. Galen, 1906 p.